A M W Van den Ouweland - JoVE Visualize

Showing results (1-10 of 17) with videos related to

Pageof 2

Sort By:

Neurologia (Barcelona, Spain)|September 16, 2006

[Tuberous sclerosis complex type 1 (TSC1): diagnostic significance of the cutaneous mini-lesions in a familial presentation]I Pascual-Castroviejo, S I Pascual-Pascual, R Velazquez, et al.

Nederlands Tijdschrift Voor Geneeskunde|February 1, 2002

[From gene to disease; craniosynostosis syndromes due to FGFR2-mutation]C M A van Ravenswaaij-Arts, A M W van den Ouweland, A J M Hoogeboom, et al.

Familial Cancer|October 11, 2019

A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literatureM D Aydemirli, K van der Tuin, F J Hes, et al.

European Journal of Medical Genetics|December 28, 2005

Hyperechogenic fetal bowel: counseling difficultiesD Marcus-Soekarman, J Offermans, A M W Van den Ouweland, et al.

Clinical Genetics|May 10, 2013

A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the NetherlandsR van Minkelen, Y van Bever, J N R Kromosoeto, et al.

Epilepsy Research|November 21, 2007

Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complexK Boer, F Jansen, M Nellist, et al.

British Journal of Cancer|February 19, 2004

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expressionL B Koppert, A W van der Velden, M van de Wetering, et al.

European Journal of Human Genetics : EJHG|November 28, 2013

Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1M E P van den Elzen, S R F Twigg, J A C Goos, et al.

Genetic Testing|October 18, 2005

Large deletion at the TSC1 locus in a family with tuberous sclerosis complexM Nellist, O Sancak, M A Goedbloed, et al.

European Journal of Endocrinology|August 13, 2015

The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defectsS H Donze, C R Meijer, S G Kant, et al.

Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:

Pageof 2

Neurologia (Barcelona, Spain)|September 16, 2006

[Tuberous sclerosis complex type 1 (TSC1): diagnostic significance of the cutaneous mini-lesions in a familial presentation]I Pascual-Castroviejo, S I Pascual-Pascual, R Velazquez, et al.

Nederlands Tijdschrift Voor Geneeskunde|February 1, 2002

[From gene to disease; craniosynostosis syndromes due to FGFR2-mutation]C M A van Ravenswaaij-Arts, A M W van den Ouweland, A J M Hoogeboom, et al.

Familial Cancer|October 11, 2019

A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literatureM D Aydemirli, K van der Tuin, F J Hes, et al.

European Journal of Medical Genetics|December 28, 2005

Hyperechogenic fetal bowel: counseling difficultiesD Marcus-Soekarman, J Offermans, A M W Van den Ouweland, et al.

Clinical Genetics|May 10, 2013

A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the NetherlandsR van Minkelen, Y van Bever, J N R Kromosoeto, et al.

Epilepsy Research|November 21, 2007

Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complexK Boer, F Jansen, M Nellist, et al.

British Journal of Cancer|February 19, 2004

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expressionL B Koppert, A W van der Velden, M van de Wetering, et al.

European Journal of Human Genetics : EJHG|November 28, 2013

Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1M E P van den Elzen, S R F Twigg, J A C Goos, et al.

Genetic Testing|October 18, 2005

Large deletion at the TSC1 locus in a family with tuberous sclerosis complexM Nellist, O Sancak, M A Goedbloed, et al.

European Journal of Endocrinology|August 13, 2015

The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defectsS H Donze, C R Meijer, S G Kant, et al.

Pageof 2